Gene expression-based products for precision oncology

GeneCentric’s products harness the power of gene expression to improve cancer diagnosis, prognosis, and therapy selection. Grounded in a decade of RNA-based biomarker innovation, and now extended to liquid biopsy through our GenomicsNext™ platform, our tools are designed to detect and track the dynamic biological activity of a tumor to deliver more precise biomarkers from tissue or blood.

Explore our gene expression-driven solutions:

PurIST^®  Tissue-based RNA expression subtyping for pancreatic cancer

GenomicsNext™ Liquid biopsy platform combining genomic alterations and gene expression from ctDNA